ANN ARBOR -- The medical device startup Everist Genomics Wednesday announced plans to commercialize its CardioDefender diagnostic system. CardioDefender is the first FDA-approved and CE ...

ANN ARBOR, Mich., Nov. 9, 2011 /PRNewswire/ — Everist Genomics, a rapidly growing personalized medicine company developing and commercializing innovative diagnostics and prognostics, today announced ...

DocGo, a mobile medical services provider, has expanded its partnership with SHL Telemedicine to integrate its 12-lead ECG devices across its mobile healthcare network nationwide, according to Stock ...

Mayo Clinic, AliveCor develop mobile EKG device to monitor patients at risk of sudden cardiac death Researchers from Rochester, Minn.-based Mayo Clinic and AliveCor, a cardiology-focused medical ...

Thanks to prominent cardiologist Eric Topol, everyone and their mother knows about AliveCor and its ability to snap on to the back of an iPhone and transmit what the company calls clinical-quality ...

Personal MedSystems introduces the first and only 22-lead mobile ECG system, CardioSecur, at the European Society of Cardiology Congress 2015. The next generation of ECG solutions can be run with a ...

The latest announcement is out from Cardiocomm Solutions ( (TSE:EKG) ).

Rockville, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The global ECG telemetry devices market is valued at US$ 2.65 billion in 2023 and is predicted to reach US$ 5.72 billion by 2033, as per a new industry ...

German airline Lufthansa has recently started using a mobile ECG system with telemedical support on all long-haul flights. The new system is intended to ensure safer travel for passengers on board in ...

New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Mobile ECG Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality, ...